KB14A

N/A

Report date: 2025/04/29 09:25:33

Base Information

Drug NameKB14A
Drug Alias NameKB-14AKB14A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of Action1,3-beta-glucan synthase inhibitors
Targets1,3-beta-glucan synthase
Therapy Area/IndicationsCandidiasisAspergillosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesKBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesKBio Inc
Inactive CompaniesN/A
Active IndicationsCandidiasisAspergillosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A